LoginGet started
Picture of Vivimed Labs logo

VIVIMEDLAB — Vivimed Labs Income Statement

0.000.00%
in flag iconLast trade - 00:00
HealthcareSpeculativeMicro Cap
Balance sheetIncome statementCashflow
Subscribe to view all data

Annual income statement for Vivimed Labs, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

2019
March 31st
2020
March 31st
2021
March 31st
2022
March 31st
2023
March 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
IAS
IAS
IAS
IAS
IAS
Status:FinalFinalFinalFinalFinal
Revenue
Total Revenue13,15210,5888,6152,3731,871
Cost of Revenue
Gross Profit5,3943,8473,671580-1,145
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses12,41911,1128,5772,6364,824
Operating Profit733-52438-263-2,953
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes660-1,095-699-648-3,307
Provision for Income Taxes
Net Income After Taxes574-1,091-719-677-3,285
Minority Interest
Net Income Before Extraordinary Items
Net Income574-1,091-719-677-3,285
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income574-1,091-719-677-3,285
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS6.67-12.6-8.67-8.16-32.6